New York S 1795: Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

Status: REFERRED TO HIGHER EDUCATION (as of 2026-01-07)

State: New York · Session: 2025-2026 · Bill: S 1795

Sponsors: Nathalia Fernandez, Lea Webb, Robert Jackson

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S01795 Summary:

BILL NOS01795 

&nbsp

SAME ASSAME AS A05029

&nbsp

SPONSORFERNANDEZ

&nbsp

COSPNSRJACKSON, WEBB

&nbsp

MLTSPNSR

&nbsp

Amd §6816-a, Ed L

&nbsp

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.

Go to top S01795 Actions:

BILL NOS01795 

&nbsp

01/13/2025REFERRED TO HIGHER EDUCATION

01/07/2026REFERRED TO HIGHER EDUCATION

Go to topS01795 Committee&nbspVotes:

Go to topS01795 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS01795 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 1795

 2025-2026 Regular Sessions

 IN SENATE

 January 13, 2025
 ___________

 Introduced by Sens. FERNANDEZ, JACKSON, WEBB -- read twice and ordered
 printed, and when printed to be committed to the Committee on Higher
 Education

 AN ACT to amend the education law, in relation to the substitution of
 brand name epinephrine auto-injectors with alternate epinephrine auto-
 injectors for dispensation by pharmacists

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Section 6816-a of the education law is amended by adding a
 2 new subdivision 6 to read as follows:
 3 6. (a) Notwithstanding subdivision two of this section or any other
 4 section of law to the contrary, when a patient is prescribed a brand
 5 name epinephrine auto-injector, a pharmacist may substitute an alternate
 6 epinephrine auto-injector containing the same active ingredients, dosage
 7 form and strength as the brand name product prescribed, ordered or
 8 demanded, regardless of whether the alternate epinephrine auto-injector
 9 is included in the latest list of interchangeable drug products for the
 10 prescribed epinephrine auto-injector device, provided that:
 11 (i) the prescriber does not indicate that the prescription therefor
 12 shall be dispensed as written pursuant to paragraph (a) of subdivision
 13 six of section sixty-eight hundred ten of this article;
 14 (ii) the alternate epinephrine auto-injector available would reflect a
 15 lower unit cost to the purchaser;
 16 (iii) the pharmacist has advised the purchaser of the availability of
 17 an alternate epinephrine auto-injector and obtained consent to dispense
 18 the alternate epinephrine auto-injector; and
 19 (iv) the pharmacist has counseled the patient or person authorized to
 20 act on the patient's behalf on the proper usage and operating features
 21 of the alternate epinephrine auto-injector.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03148-01-5

 S. 1795 2

 1 (b) For purposes of this subdivision "epinephrine auto-injector" shall
 2 have the same meaning as provided in paragraph (b) of subdivision one of
 3 section three thousand-c of the public health law.
 4 § 2. This act shall take effect immediately.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps

View New York S 1795 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.